Hepatocellular carcinoma-specific immunotherapy with synthesized &alpha;1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells

doi:10.3748/wjg.v17.i48.5260

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4566)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

418

HTML

3831

Figures (1-2)

161

Tables (1-2)

156

Sum=4566

Dec 28, 2011 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2011; 17(48): 5260-5266
Published online Dec 28, 2011. doi: 10.3748/wjg.v17.i48.5260

Full Size Figure Download Figure

Figure 2 Kaplan Meier survival curves of the patients with stage III hepatocellular carcinoma. Study group, n = 9; control group, n = 9; P = 0.00121.

Citation: Qiu Y, Xu MB, Yun MM, Wang YZ, Zhang RM, Meng XK, Ou-Yang XH, Yun S. Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J Gastroenterol 2011; 17(48): 5260-5266
URL: https://www.wjgnet.com/1007-9327/full/v17/i48/5260.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i48.5260